Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, announced the launch in the European Union of Abraxane® Paclitaxel 5 mg/ml powder for suspension for infusion. Abraxane® is an albumin-bound nanoparticle formulation of paclitaxel.
More...